Ambroxol reduces LPS toxicity mediated by induction of alkaline phosphatases in rat lung

Clinical Biochemistry

Volumn 37, Issue 8, 2004, Pages 688-693

  Koyama, Iwao ^a   Matsunaga, Toshiyuki ^a   Harada, Tsuyoshi ^a   Kikuno, Akira ^a   Hokari, Shigeru ^a   Komoda, Tsugikazu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alkaline phosphatases; Ambroxol; Detoxicification; Lipopolysaccharides; Rat lung; Surfactant particles

Indexed keywords

ALKALINE PHOSPHATASE; AMBROXOL; BROMHEXINE; EXPECTORANT AGENT; LIPOPOLYSACCHARIDE; SURFACTANT ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LIPID BLOOD LEVEL; LUNG; MALE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; AMBROXOL; ANIMALS; AREA UNDER CURVE; BLOTTING, WESTERN; BRONCHI; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPECTORANTS; LIPOPOLYSACCHARIDES; LUNG; MALE; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 4043052923     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.02.004     Document Type: Article

References (32)

1. Waymire K.G., Mahuren J.D., Jaje J.M., Guilarte T.R., Coburn S.P., MacGrefor G.R. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat. Genet. 11:1995;45-51
2. Irino T., Matsushita M., Sakagishi Y., Komoda T. Phosphorylcholine as a unique substrate for human intestinal alkaline phosphatase. Int. J. Biochem. 26:1994;273-277
3. Li-Chan E., Nakai S. Enzymic dephosphorylation of bovine casein to improve acid clotting properties and digestibility for infant formula. J. Dairy Res. 56:1989;381-390
4. Mahmood A., Mahmood S., DeSchryver-Kecskemeti K., Alpers D.H. Characterization of proteins in rat and human intestinal surfactant-like particles. Arch. Biochem. Biophys. 300:1993;280-286
5. Eliakim R., Goetz G.S., Rubio S., Chailley-Heu B., Shao J.S., Ducroc R., et al. Isolation and characterization of surfactant-like particles in rat and human colon. Am. J. Physiol. 272:1997;G425-G434
6. Edelson J.D., Shannon J.M., Mason R.J. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am. Rev. Respir. Dis. 138:1988;1268-1275
7. Rietschel E.T., Kirikae T., Sdnde F.U., Mamat U., Schmidt G., Loppnow H., et al. Bacterial endotoxin: molecular relationship of structure to activity and function. FASEB J. 8:1994;217-225
8. Lopez A., Yong S. Injury versus inflammatory response in the lungs of rats intratracheally inoculated with bacterial lipopolysaccharides. Am. J. Vet. Res. 47:1986;1287-1292
9. Harada T., Koyama I., Shimoi A., Alpers D.H., Komoda T. Identification of pulmonary surfactants bearing intestinal-type and tissue-nonspecific alkaline phosphatase in endotoxin-induced rat bronchoalveolar fluid. Cell Tissue Res. 307:2002;69-77
10. McIntosh J.C., Swyers A.H., Fisher J.H., Wright J.R. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 15:1996;509-519
11. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complex of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433
12. Detmers P.A., Zhou D., Powell E.D. Different signaling pathways for CD18-mediated adhesion and Fc-mediated phagocytosis. Response of neutrophils to LPS. J. Immunol. 153:1994;2137-2145
13. Poelstra K.W., Bakker W.W., Klok P.A., Kamps J.A.A., Hardonk M.J., Meijer D.K. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am. J. Pathol. 151:1997;1163-1169
14. Koyama I., Matsunaga T., Harada T., Hokari S., Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 35:2002;455-461
15. Disse B.G. The pharmacology of ambroxol. Eur. J. Respir. Dis. 153:1987;255-262
16. Ecker H., Lux M., Lachmann B. The role of alveolar macrophages in surfactant turnover. An experimental study with metabolite VIII of bromhexine. Lung. 161:1983;213-218
17. Sumano H., Gracia I., Capistran A., Meade G., Rivero A., Ruiz-Ramirez L. Use of ambroxol and bromhexine as mucolytics for enhanced diffusion of furaltadone into tracheobronchial secretions in broilers. Br. Poult. Sci. 36:1995;503-507
18. Nowk D.A., Antezak A., Pietras T., Bialasiewicz P., Krol M. Protective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipids in mice. Eur. Respir. J. 7:1994;1629-1634
19. Lee C.S., Jang Y.Y., Han E.S. Depressant effects of ambroxol on lipopoly-saccharide- or fMLP-stimulated free radical production and granule enzyme release by alveolar macrophages. Pulm. Pharmacol. Ther. 72:1999;275-284
20. Yang B., Yao D.F., Ohuchi M., Ide M., Yano M., Okumura Y., et al. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor level. Eur. Respir. J. 19:2002;952-958
21. Koyama I., Harada T., Matsunaga T., Hokari S., Tsumura M., Katayama H., et al. Inflammatory response and expression of pulmonary alkaline phosphatases in rats challenged with lipopolysaccharides. Jpn. J. Electrophor. 45:2001;177-183
22. Fujimori-Arai Y., Koyama I., Hirano K., Sakagishi Y., Komoda T. Purification and partial characterization of intestinal-like alkaline phosphatase in rabbit kidney. Arch. Biochem. Biophys. 284:1991;320-325
23. Furukawa T., Kubota T., Hoffman R.M. Clinical application of the histoculture drug response assay. Clin. Cancer Res. 1:1995;305-311
24. Tamura H., Tanaka S., Obayashi T., Yoshida M., Kawai T. A new sensitive method for determining endotoxin in whole blood. Clin. Chim. Acta. 200:1991;35-42
25. Cobben N.A., Drent M., Jacobs J.A., Schmitz M.P., Mulder P.G., Henderson R.F., et al. Relationship between enzymatic markers of pulmonary cell damage and cellular profile: a study in bronchoalveolar lavage fluid. Exp. Lung Res. 25:1999;99-111
26. Gutierrez H.H., Pitt B.R., Schwarz M., Watkins S.C., Lowenstein C., Caniggia I., et al. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am. J. Physiol. 268:1995;L501-L508
27. Jang Y.Y., Song J.H., Shin Y.K., Han S.E., Lee C.S. Depressant effects of ambroxol and endosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide. Pharmacol. Toxicol. 92:2003;173-179
28. Freudenberg M.A., Galanos C. Gamma interferon production in endotoxin-responder and -nonresponder mice during infection. Infect. Immun. 59:1991;2110-2115
29. Gillissen A., Nowak D. Characterization of N0 acetylcysteine and ambroxol in antioxidant therapy. Respir. Med. 92:1998;609-623
30. Fukushima K., Sasaki I., Takahashi K., Naito H., Ogawa H., Sato S., et al. Lipopolysaccharide exhibits synergistic enhancement of butyrate-induced and retinoic acid-mediated alkaline phosphatase activity on small intestinal epithelial cell line, IEC-6. Digestion. 59:1998;683-688
31. Matsunaga T., Nakajima T., Sonoda M., Kawai S., Kobayashi J., Inoue I., et al. Reactive oxygen species as a risk factor in verotoxin-1-exposed rat. Biochem. Biophys. Res. Commun. 260:1999;813-819
32. Koyama I., Yakushijin M., Goseki M., Iimura T., Sato T., Sonoda M., et al. Partial breakdown of glycated alkaline phosphatases mediated by reactive oxygen species. Clin. Chim. Acta. 275:1998;27-41